Hypercalcemia on ECG

What it looks like on ECG

The most characteristic ECG change in hypercalcemia is shortening of the QT interval, which occurs primarily due to reduction of the ST segment. The T wave often retains its normal shape, but "approaches" the QRS complex with almost no pause, so the transition from S to T looks sharp, and sometimes the ST segment is practically undetectable as a separate segment. This sign may be absent or mild even in confirmed hypercalcemia, so the ECG does not replace biochemical blood testing.

The QT interval is measured in a lead with a clearly distinguishable QRS onset and T wave end, usually choosing the longest reliably measurable interval and checking several leads; leads II and V5–V6 are often convenient for this, where the T wave is well expressed and there is no U-wave superimposition. For comparison at different heart rates, correction is used (Bazett or Fridericia formula), but guidelines do not establish a strict linear relationship and unambiguous threshold (as, for example, for prolonged QT) for diagnosing hypercalcemia — clinicians rely on dynamics, clinical context, and the degree of shortening.

In moderate hypercalcemia, ECG changes may be limited solely to QT shortening, with rhythm and conduction remaining unchanged. In pronounced and severe hypercalcemia (hypercalcemic crisis), the following may join:

QT shortening due to ST is more characteristic of hypercalcemia, whereas peaked narrow T waves are more characteristic of early hyperkalemia; however, T wave shape and amplitude overlap significantly between these conditions and depend on many factors, so a single ECG cannot reliably differentiate the contribution of each electrolyte — laboratory testing is required.

Mechanism

Calcium participates in phase 2 (plateau) of the cardiomyocyte action potential, where a slow inward calcium current through L-type channels maintains the depolarized state of the membrane. Increased extracellular calcium alters the electrophysiology of the action potential plateau and accelerates its termination, which predominantly shortens the ST segment and, accordingly, the entire QT interval. The T wave primarily reflects ventricular repolarization and does not change as predictably, so QT shortening occurs mainly at the expense of the ST segment rather than the T wave, although this pattern is inconstant. At very high calcium levels, conduction through the AV node and the His-Purkinje system is also impaired, which can lead to PR prolongation and QRS widening.

Causes

• Primary hyperparathyroidism (the most common cause in outpatient practice)
• Malignant neoplasms (paraneoplastic hypercalcemia, bone metastases, secretion of PTH-related peptide)
• Excessive intake of calcium supplements and vitamin D
• Thyrotoxicosis
• Prolonged immobilization
• Granulomatous diseases (sarcoidosis, tuberculosis)
• Thiazide diuretic overdose
• Milk-alkali syndrome
• Chronic kidney disease with tertiary hyperparathyroidism or iatrogenic calcium/vitamin D overload

Differential diagnosis

• Short QT syndrome (congenital) — QT shortening without electrolyte disturbances, often with tall symmetric T waves and a family history of sudden death
• Hyperkalemia — may also accompany hypercalcemia; typically produces peaked narrow T waves, but severe hyperkalemia can also flatten or eliminate the P wave, prolong the PR interval, and widen the QRS complex up to a sine wave pattern; in combined disorders, the contribution of each electrolyte cannot be reliably separated from a single ECG, and laboratory data are required.
• Digoxin effect on ECG — QT shortening with characteristic "scooped-out" ST depression (the ST segment sags rather than disappears), often with altered T wave morphology.
• Tachycardia — the absolute QT interval is physiologically shortened with an increased heart rate; QTc must be evaluated, preferably using Fridericia's formula or another validated method, taking into account the limitations of all correction formulas. Tachycardia alone does not explain a truly shortened QTc — if QTc remains low after correct correction, an electrolyte or other cause should be sought rather than attributing it to the heart rate.

Clinical significance and management

ECG changes in hypercalcemia rarely cause life-threatening arrhythmias on their own, but serve as an important and rapid clinical marker: QT shortening in a patient with symptoms (weakness, nausea, polyuria, bone pain, confusion) should raise suspicion for hypercalcemia and prompt biochemical testing: total calcium with albumin or ionized calcium, creatinine/eGFR, phosphate, and magnesium; once hypercalcemia is confirmed, check PTH and further investigate the cause.

In severe hypercalcemia with bradycardia, PR prolongation, and QRS widening, the risk increases — progression of AV block and cardiac arrest in systole (asystole against the background of extremely high calcium has been described as a case report) are possible. Such changes require urgent assessment of calcium levels and initiation of pathogenetic therapy for hypercalcemic crisis in an inpatient setting.

It is important for the functional diagnostics physician: upon detecting QT shortening without an obvious cause (not tachycardia, not digoxin), recommend checking calcium, potassium, and magnesium, primarily to identify concomitant disorders. Hypomagnesemia typically prolongs the QT interval and increases the risk of torsades de pointes rather than shortening it; typical causes of a short QT include hypercalcemia, hyperkalemia, hyperthermia, acidosis, as well as a number of drug-induced and congenital conditions.

Common interpretation errors

• Failing to measure the QT interval and missing the single significant, albeit inconstant, sign — interval shortening
• Relying on a rigid numerical QTc threshold as a diagnostic criterion for hypercalcemia, although no such threshold exists in guidelines
• Confusing QT shortening in hypercalcemia with the peaked T waves of hyperkalemia, although T wave morphology in both conditions can overlap
• Failing to account for heart rate when assessing an uncorrected QT interval, while remembering that Bazett's formula overestimates QTc at high heart rates and underestimates it at low heart rates
• Ignoring the clinical context (oncology, vitamin D therapy, symptoms) upon an incidental finding of a short QT
• Attributing bradycardia and AV block solely to hypercalcemia without ruling out concurrent hyperkalemia or medication use

Frequently asked questions

Related terms

More in "Electrolytes and Metabolism"

Entire section

Sources

• Goldberger's Clinical Electrocardiography, latest edition
• Surawicz B., Knilans T. Chou's Electrocardiography in Clinical Practice
• Orlov V.N. Guide to Electrocardiography

Educational material for medical students and physicians. Does not replace clinical guidelines and physical examination; the ECG must always be interpreted in conjunction with the clinical picture.